Home > What We Treat > Primary Brain Tumors
Primary Brain Tumors - Physician Information
Information for Patients
Research Support
By definition, a primary brain tumor is a growth originating within the
brain. The common clinical situation is an individual who presents with a
lesion in the brain and has no known source of tumor elsewhere in the body;
hence there is no reason to suspect spread of tumor to the brain from elsewhere.
Therefore, in contrast to the situation with metastatic tumors, surgical
verification of the identity of the tumor is almost always necessary. The
exception to this rule is if imaging studies have such a typical appearance
that their identity may be assumed with a very high probability.
The tumors which can frequently be identified with such high probability
are meningiomas, acoustic neuromas, and pituitary adenomas. These tumors
can be treated with gamma knife with little likelihood that a diagnosis based
on imaging is in error. These tumors also share the characteristic that they
usually appear on MRI scans as discrete masses arising outside the brain,
rather than from the brain tissue itself. Surgery to reduce their size or
remove them completely may still be advisable, depending upon the assessment
of risks inherent to the procedure and the threat that presence of the tumor
causes. Most of these tumors also share the characteristic that their growth
is slow.
Although the gamma knife has been in use for over two decades, the ability
to control these tumors over a span of many decades has not been determined.
Consequently, gamma knife is more typically used in older patients and surgery
is more frequently used in the young. The effect of the gamma knife upon
slowly growing tumors is gradual, and tumors threatening vision or vital
functions are generally treated surgically, with gamma knife reserved for
adjuvant therapy if required. Studies suggest that the long-term control
of these tumors by gamma knife therapy varies between 80 and 95 per cent,
depending upon tumor size, type, and length of follow up of the study.
Tumors arising from within brain tissue are different in that usually it
is not possible to remove them completely by operation. This is due in part
to the lack of diagnostic imaging which can accurately show the margins of
the tumor, and partially because the most common examples of such tumors
- astrocytoma and glioblastoma - tend to infiltrate the surrounding tissue
invisibly, sometimes spreading distantly along fiber tracts. Surgery is almost
always necessary to diagnose these tumors accurately, and to reduce their
size to render them more susceptible to adjuvant therapies such as gamma
knife, fractionated teletherapy, or chemotherapy. The tissue obtained at
operation allows the pathologist to determine how aggressively the tumor
is likely to behave.
Tumors are graded by pathologists from I through IV (glioblastoma), in order
of worsening aggressiveness. There is a tendency over time for low grade
tumors to progress to a higher grade. Average survival decreases the higher
the grade of the tumor. Many factors influence survival, including age, general
health, which brain functions are impaired by the tumor, and response of
the tumor to treatment - whether surgical, chemotherapeutic, or radiotherapeutic.
Adjuvant therapy is almost always advisable in grade III or IV tumors, sometimes
in lower grade tumors. Because of the infiltrative nature of these tumors,
the mainstay of radiation therapy is usually fractionated teletherapy delivered
in small doses over several weeks with a linear accelerator.
Gamma Knife can augment this by boosting the radiation dose to a localized
residual portion of tumor after operation or a localized recurrence. Because
the effectiveness of any adjuvant therapy depends on the volume of tumor
present, patients are usually followed at intervals of 2 to 3 months with
MRI scans so that progression of tumor can be detected early. Studies are
in progress to assess the exact contribution that gamma knife can make to
survival, but experience with individual cases suggests that sometimes the
contribution can be quite significant.
Research Support |